Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.
D000230:Adenocarcinoma / Q000150:complications* / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D000328:Adult; D000368:Aged; D002277:Carcinoma / Q000150:complications* / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery; D002369:Castration; D004054:Diethylstilbestrol / Q000008:administration & dosage* / Q000627:therapeutic use*; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D007484:Iowa; D007796:Laminectomy; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009392:Nephrectomy; D010243:Paralysis / Q000188:drug therapy* / Q000209:etiology; D010264:Paraplegia / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery; D010761:Phosphorus Radioisotopes; D011471:Prostatic Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery
D004967:Estrogens; D010761:Phosphorus Radioisotopes; D004054:Diethylstilbestrol